Last updated: July 2022
This application seeks to permit 2′-fucosyllactose (2′-FL), produced by genetically modified
Escherichia coli K-12, in infant formula products.
Approval report - 6 May 2022(pdf 363 kb)(word 170 kb)
Supporting document 1 - Safety assessment at approval (pdf 410 kb)(word 323 kb)
Call for submissions
Call for submissions - 6 December 2021(pdf 308 kb) (word 143 kb)
Supporting document 1 - Safety assessment (pdf 408 kb) (word 322 kb)
Submissions(zip 1.64 mb)
Administrative Assessment - 3 August 2021 (pdf 94.8 kb)(word 67.8 kb)
Executive Summary (pdf 51.2 kb)
Application (pdf 467 kb)
Applications published on our website may contain material owned by a third party. If you wish to re-use third party material, you may need to seek permission from the copyright owner.